Patents by Inventor Jae-Sung Yeon

Jae-Sung Yeon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210322490
    Abstract: The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Bifidobacterium bifidum MG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Bifidobacterium bifidum MG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novel Lactococcus lactis GEN3033 strain and a composition for preventing or treating cancers, comprising the same.
    Type: Application
    Filed: May 8, 2019
    Publication date: October 21, 2021
    Applicant: Genome And Company
    Inventors: Hansoo Park, Shinyoung Park, Eun Ju Lee, Jae-Sung Yeon, Hye Hee Jeon, Wonduck Kim, Joo-Yeon Chung, Areum Jeong, Youn Kyung Houh, Jinyoung Sohn, Yun Yeon Kim, Sang Gyun Kim, Suro Lee
  • Publication number: 20210138003
    Abstract: The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Bifidobacterium bifidum MG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Bifidobacterium bifidum MG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novel Lactococcus lactis GEN3033 strain and a composition for preventing or treating cancers, comprising the same.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 13, 2021
    Applicant: Genome And Company
    Inventors: Hansoo Park, Shinyoung Park, Eun Ju Lee, Jae-Sung Yeon, Hye Hee Jeon, Wonduck Kim, Joo-Yeon Chung, Areum Jeong, Youn Kyung Houh, Jinyoung Sohn, Yun Yeon Kim, Sang Gyun Kim, Suro Lee
  • Patent number: 9238929
    Abstract: A door locking apparatus and an enclosure comprising the same are disclosed. The door locking apparatus comprises an operation unit 52 installed on a door 30 for opening/closing a body frame 10, and one or more locking units 80 installed in the door 30 to be capable of being inserted into or released from a locking hole 11 formed in the body frame 30. At least one of the locking units 80 comprises an unlocking restraint module 83, 84 operated by an external force and caught by the body frame 10.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: January 19, 2016
    Assignee: LG N-SYS, INC.
    Inventors: Woo Youn Cho, Se Hoon Park, Jae Sung Yeon, Jang Wook Choi, Kwang Hun Ko, Sung Yong Oh
  • Publication number: 20130038192
    Abstract: Disclosed is a damper and an opening/closing apparatus and a financial device using the same. The damper has first and second bodies mounted on fixed and rotatable objects, respectively, to perform a damping action during an end of the rotation range of opening/closing the rotatable object, abrupt operation of which is thus prevented. The first body has a damping space filled with a damping material and fixed and movable friction plates are installed in the damping space so that the movable friction plate rotates together with a rotation center shaft in a specific range. First and second interlock surfaces are positioned on opposite sides of the rotation center shaft, and first and second interlock stages are formed at a predetermined angle on both stages of the inner surface of a shaft through-hole of the movable friction plate so as to selectively contact the interlock surfaces, respectively.
    Type: Application
    Filed: August 9, 2012
    Publication date: February 14, 2013
    Applicant: LG N-SYS INC.
    Inventors: Woo-Youn Cho, Se-Hoon Park, Jae-Sung Yeon, Jang-Wook Choi, Kwang-Hun Ko